1
|
Leonhardt T, Skula J, Müller B, Schulthess P, Jeisy J, Riedl W. (Semi)-Kontinuierliche Synthese von Produkten für die Pharma- oder Feinchemie in einem neuartigen Rohrreaktor im Pilotmaßstab. CHEM-ING-TECH 2018. [DOI: 10.1002/cite.201855215] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- T. Leonhardt
- Fachhochschule Nordwestschweiz, Hochschule für Life Sciences; Institut für Chemie und Bioanalytik; Hofackerstraße 30 4132 Muttenz Schweiz
| | - J. Skula
- Fachhochschule Nordwestschweiz, Hochschule für Life Sciences; Institut für Chemie und Bioanalytik; Hofackerstraße 30 4132 Muttenz Schweiz
| | - B. Müller
- Fachhochschule Nordwestschweiz, Hochschule für Life Sciences; Institut für Chemie und Bioanalytik; Hofackerstraße 30 4132 Muttenz Schweiz
| | - P. Schulthess
- Fachhochschule Nordwestschweiz, Hochschule für Life Sciences; Institut für Chemie und Bioanalytik; Hofackerstraße 30 4132 Muttenz Schweiz
| | - J. Jeisy
- eh. F. Hoffmann-La Roche AG; Hauptstraße 54 4148 Pfeffingen Schweiz
| | - W. Riedl
- Fachhochschule Nordwestschweiz, Hochschule für Life Sciences; Institut für Chemie und Bioanalytik; Hofackerstraße 30 4132 Muttenz Schweiz
| |
Collapse
|
2
|
Leonhardt T, Zogg A, Hutter C, Jeisy J, Riedl W. Entwicklung eines Rohrreaktorsystems zur Durchführung von Mehrphasenreaktionen im Labormaßstab. CHEM-ING-TECH 2016. [DOI: 10.1002/cite.201650274] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
|
3
|
Leonhardt T, Jeisy J, Hutter C, Herzog F, Hug A. Zero Emission - Möglichkeiten der Kryokondensation: ein energetischer Vergleich mit der thermischen Abgasverbrennung. CHEM-ING-TECH 2014. [DOI: 10.1002/cite.201450104] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
4
|
|
5
|
Leonhardt T. [The "dental amalgam syndrome" - an environmental somatization Syndrome? A comparison between chronic carbon monoxide intoxication and illness related to dental amalgam]. Dan Medicinhist Arbog 2002:177-86. [PMID: 11855370] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/23/2023]
Abstract
In 1940, during World War II, restrictions in import of petroleum products to Sweden necessitated the use of producer gas in motor traffic. In the following years, the incidence of acute carbon monoxide intoxications raised steeply. However, many patients with minor but longstanding exposition to producer gas exhibited a neurastenic syndrome (fatigue, headaches and vertigo) thought to be specific. In Stockholm, an epidemic of this syndrome can afterwards be traced to the personal conviction of an internist who also had an important influence on various authorities, leading to a forceful campaign to the public about the dangers of using producer gas. After some years, the frequency and even the existence of a chronic carbon monoxide intoxication was called in question and at the end of the war that diagnosis lost its actuality. In Sweden, oral galvanism attributed to dental amalgam was discussed in mass media in the 1970s, not least by evidence given by some well-known personalities. In the 1980s, the frequency of illness attributed to dental amalgam increased to an important epidemic. The question of the dangers of mercury released from amalgam fillings is still an important issue of debate among dentists and physicians, although the majority remains sceptical. Also medical authorities have found little evidence of the importance of dental amalgam toxicity. A patients organisation, Tandvårdsskadeförbundet, seems to have played a significant part in the acceptance of the syndrome among laymen. Thus, various psychosocial factors seem to have played a role in both syndromes which could thus be conceived as environmental somatization syndromes.
Collapse
|
6
|
Leonhardt T. [Psychosomatic disease or infection? Peptic ulcer in the light of the history of ideas and of the philosophy of science]. Sven Med Tidskr 2001; 3:133-61. [PMID: 11625670] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/21/2023]
Abstract
Chronic benignant ulcers of the stomach were considered as a disease entity not until in the 1830s, when Jean Cruveilhier and others compared disease history with pathological findings at autopsy. Ulcers of the duodenal bulb were thought unusual until in the beginning of the twentieth century, when abdominal surgery was rapidly developing and X-ray introduced as a diagnostic tool intra vitam. Duodenal ulcers and distal ventricular ulcers have a similar symptomatology and are often associated with hyperacidity. They are therefore jointly spoken as a peptic ulcer disease. Trauma and dietetic faults, hyperacidity and local circulatory disturbances were considered important etiological and pathogenetical factors in the nineteenth century. In the 1910s, instability of the vegetative (autonomic) nervous system was coined as an additional factor. However, the most important concept of the nature of peptic ulcer emerged in the 1940s, when it was appointed a psychosomatic disease. Psychoanalysis and stress research were the main sources of this concept which was predominant until recently. In the middle of the 1980s, gastric infection with a bacillus, later named Helicobacter pylori, was demonstrated to be strongly associated with peptic ulcer and is now considered as its main cause. This finding has also had an important impact on the treatment of peptic ulcer, which is now mainly pharmacological. Thus, a biogenetic view of peptic ulcer disease has superseded a psychogenetic one. The author thus proposes that the history of peptic ulcer can be divided into four periods or stages, comparable to the paradigmal shifts of Kuhn, according to the prevailing concepts of the disease. It is however concluded that peptic ulcer is no unicausal or monolithic unity but rather a syndrome with a complex etiology and pathogenesis. It is important to maintain a holistic view of the diseased individual.
Collapse
|
7
|
Leonhardt T. [The amalgam syndrome from a historical perspective. The Swedish amalgam disease epidemics]. Lakartidningen 2001; 98:3940-5, 3947-8. [PMID: 11586835] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/21/2023]
|
8
|
Leonhardt T. [The amalgam syndrome seen in the perspective of history of ideas. Mercury--useful product and health hazard]. Lakartidningen 2001; 98:3817-22, 3824. [PMID: 11586816] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/21/2023]
|
9
|
Leonhardt T. [Etiology of fibromyalgia still not clarified]. Lakartidningen 2000; 97:4181. [PMID: 11068392] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/18/2023]
|
10
|
Bruno V, Ksiazek I, Battaglia G, Lukic S, Leonhardt T, Sauer D, Gasparini F, Kuhn R, Nicoletti F, Flor PJ. Selective blockade of metabotropic glutamate receptor subtype 5 is neuroprotective. Neuropharmacology 2000; 39:2223-30. [PMID: 10974306 DOI: 10.1016/s0028-3908(00)00079-4] [Citation(s) in RCA: 102] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
Abstract
We have used potent and selective non-competitive antagonists of metabotropic glutamate receptor subtype 5 (mGlu5) -- 2-methyl-6-phenylethynylpyridine (MPEP), [6-methyl-2-(phenylazo)-3-pyridinol] (SIB-1757) and [(E)-2-methyl-6-(2-phenylethenyl)pyridine] (SIB-1893) - to examine whether endogenous activation of this particular metabotropic glutamate receptor subtype contributes to neuronal degeneration. In cortical cultures challenged with N-methyl-D-aspartate (NMDA), all three mGlu5 receptor antagonists were neuroprotective. The effect of MPEP was highly specific because the close analogue, 3-methyl-6-phenylethynylpyridine (iso-MPEP), which did not antagonize heterologously expressed mGlu5 receptors, was devoid of activity on NMDA toxicity. Neuroprotection by mGlu5 receptor antagonists was also observed in cortical cultures challenged with a toxic concentration of beta-amyloid peptide. We have also examined the effect of mGlu5 receptor antagonists in in vivo models of excitotoxic degeneration. MPEP and SIB-1893 were neuroprotective against neuronal damage induced by intrastriatal injection of NMDA or quinolinic acid. These results indicate that mGlu5 receptors represent a suitable target for novel neuroprotective agents of potential application in neurodegenerative disorders.
Collapse
Affiliation(s)
- V Bruno
- Istituto Neurologico Mediterraneo - Neuromed, Pozzilli, Italy
| | | | | | | | | | | | | | | | | | | |
Collapse
|
11
|
Bruno V, Battaglia G, Ksiazek I, van der Putten H, Catania MV, Giuffrida R, Lukic S, Leonhardt T, Inderbitzin W, Gasparini F, Kuhn R, Hampson DR, Nicoletti F, Flor PJ. Selective activation of mGlu4 metabotropic glutamate receptors is protective against excitotoxic neuronal death. J Neurosci 2000; 20:6413-20. [PMID: 10964947 PMCID: PMC6772963] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/17/2023] Open
Abstract
Activation of group III metabotropic glutamate receptors (mGluR4, mGluR6, mGluR7, and mGluR8) has been established to be neuroprotective in vitro and in vivo. To disclose the identity of the receptor subtype(s) that exert(s) the protective effect, we have used group III agonists in combination with mGluR4 subtype-deficient mice (-/-). In cortical cultures prepared from wild-type (+/+) mice and exposed to a toxic pulse of NMDA, the selective group III agonist (+)-4-phosphonophenylglycine [(+)-PPG] reversed excitotoxicity with an EC(50) value of 4.9 microm, whereas its enantiomer (-)-PPG was inactive. This correlated closely with the potency of (+)-PPG in activating recombinant mGluR4a. In cortical neurons from -/- mice, (+)-PPG showed no protection against the NMDA insult up to 300 microm, whereas group I/II mGluR ligands still retained their protective activity. Classical group III agonists (l-2-amino-4-phosphonobutyrate and l-serine-O-phosphate) were also substantially neuroprotective against NMDA toxicity in +/+ and heterozygous (+/-) cultures but were inactive in -/- cultures. Interestingly, -/- cultures were more vulnerable to low concentrations of NMDA and showed higher extracellular glutamate levels compared with +/+ cultures. We have also examined neurodegeneration induced by intrastriatal infusion of NMDA in wild-type or mGluR4-deficient mice. Low doses of (R,S)-PPG (10 nmol/0.5 microl) substantially reduced NMDA toxicity in +/+ mice but were ineffective in -/- mice. Higher doses of (R,S)-PPG were neuroprotective in both strains of animals. Finally, microdialysis studies showed that intrastriatal infusion of NMDA increased extracellular glutamate levels to a greater extent in -/- than in +/+ mice, supporting the hypothesis that the mGluR4 subtype is necessary for the maintenance of the homeostasis of extracellular glutamate levels.
Collapse
Affiliation(s)
- V Bruno
- Istituto Neurologico Mediterraneo Neuromed, 86077 Pozzilli, Italy
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
12
|
Leonhardt T. [Reply to a comment: Why did the diagnosis fibromyalgia first appear at the end of the 20th century?]. Lakartidningen 2000; 97:3509-10. [PMID: 11037598] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/18/2023]
|
13
|
Leonhardt T. [Fibromyalgia--a new name of an old "malady". Fatigue and pain syndrome with a historical background]. Lakartidningen 2000; 97:2618-20, 2623-4. [PMID: 10881523] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/16/2023]
Abstract
Fibromyalgia is a good illustration of the fact that a smart new name of an old malady can spread like wildfire if well matched in time socioculturally. "Muscular rheumatism" has earlier been looked upon as a (rheumatic) inflammation of muscle cells or of muscular connective tissue. During the last decades the interest of leading clinicians and researchers have been directed against the pain perceiving system, suggesting defect pain modulating mechanisms peripherally and centrally. Fibromyalgia seems to supply several medical and social needs in our time and might be called a "fin-de-siècle" disease.
Collapse
|
14
|
Leonhardt T. [Chronic fatigue syndrome--old wine in new bottles]. Lakartidningen 2000; 97:182-4. [PMID: 10687349] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/15/2023]
|
15
|
Gasparini F, Bruno V, Battaglia G, Lukic S, Leonhardt T, Inderbitzin W, Laurie D, Sommer B, Varney MA, Hess SD, Johnson EC, Kuhn R, Urwyler S, Sauer D, Portet C, Schmutz M, Nicoletti F, Flor PJ. (R,S)-4-phosphonophenylglycine, a potent and selective group III metabotropic glutamate receptor agonist, is anticonvulsive and neuroprotective in vivo. J Pharmacol Exp Ther 1999; 289:1678-87. [PMID: 10336568] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023] Open
Abstract
Group III metabotropic glutamate receptors (mGluRs) are thought to modulate neurotoxicity of excitatory amino acids, via mechanisms of presynaptic inhibition, such as regulation of neurotransmitter release. Here, we describe (R,S)-4-phosphonophenylglycine (PPG) as a novel, potent, and selective agonist for group III mGluRs. In recombinant cell lines expressing the human receptors hmGluR4a, hmGluR6, hmGluR7b, or hmGluR8a, EC50 values for (R,S)-PPG of 5.2 +/- 0.7 microM, 4.7 +/- 0.9 microM, 185 +/- 42 microM, and 0.2 +/- 0.1 microM, respectively, were measured. The compound showed EC50 and IC50 values of >/=200 microM at group I and II hmGluRs and was inactive at cloned human N-methyl-D-aspartate, alpha-amino-3-hydroxy-5-methyl-isoxazole-4-propionate, and kainate receptors (>300 microM). On the other hand, it showed micromolar affinity for a Ca2+/Cl--dependent L-glutamate binding site in rat brain, similar to other phosphono-substituted amino acids like L-2-amino-4-phosphonobutyrate. In cultured cortical neurons, (R, S)-PPG provided protection against a toxic pulse of N-methyl-D-aspartate (EC50 = 12 microM), which was reversed by the group III mGluR antagonist (R,S)-alpha-methylserine-O-phosphate but not by the group II antagonist (2S)-alpha-ethylglutamate. Moreover, (R,S)-PPG protected against N-methyl-D-aspartate- and quinolinic acid-induced striatal lesions in rats and was anticonvulsive in the maximal electroshock model in mice. In contrast to the group III mGluR agonists L-2-amino-4-phosphonobutyrate and L-serine-O-phosphate, (R,S)-PPG showed no proconvulsive effects (2200 nmol i.c.v.). These data provide novel in vivo evidence for group III mGluRs as attractive targets for neuroprotective and anticonvulsive therapy. Also, (R,S)-PPG represents an attractive tool to analyze the roles of group III mGluRs in nervous system physiology and pathology.
Collapse
Affiliation(s)
- F Gasparini
- Novartis Pharma AG, Nervous System Research, Basel, Switzerland
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
16
|
Leonhardt T. [Stress, adverse effects of drugs or infection? There is a whole succession of theories on the pathogenesis of stomach ulcer]. Lakartidningen 1997; 94:2941-4. [PMID: 9312608] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Affiliation(s)
- T Leonhardt
- Medicinkliniken, Norra Alvsborgs Länssjukhus (NAL), Trollhättan
| |
Collapse
|
17
|
Flor PJ, Van Der Putten H, Rüegg D, Lukic S, Leonhardt T, Bence M, Sansig G, Knöpfel T, Kuhn R. A novel splice variant of a metabotropic glutamate receptor, human mGluR7b. Neuropharmacology 1997; 36:153-9. [PMID: 9144652 DOI: 10.1016/s0028-3908(96)00176-1] [Citation(s) in RCA: 90] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
Two splice variants of the human metabotropic glutamate receptor 7, named hmGluR7a and hmGluR7b, were isolated from a human brain cDNA library. The isoforms differ by an out-of-frame insertion of 92 nucleotides close to the C-terminus of the hmGluR7 coding region, hmGluR7a has a length of 915 amino acids and represents the human homolog of the recently cloned rat mGluR7. hmGluR7b is seven amino acids longer and exhibits a novel C-terminus of 23 amino acids in length. RT-PCR analysis demonstrated the existence of mGluR7b transcripts in wild-type mouse brain and its absence in mGluR7 knockout mice. Northern blot analysis indicate that mGluR7 expression is developmentally regulated. It is expressed at high levels in human fetal brain and at a lower level in many regions of adult human brain. Stimulation of hmGluR7b with L-2-amino-4-phosphonobutyrate (L-AP4), L-serine-O-phosphate (L-SOP) or L-glutamate in stably transfected Chinese hamster ovary (CHO) cells depressed forskolin-induced cAMP accumulation, whereas (1S,3R)-1-aminocyclopentane-1,3,-dicarboxylic acid ((1S,3R)-ACPD) and quisqualate (both at 1mM) had no significant effects. As described for rat mGluR7, the rank order of agonist potencies is: L-SOP, L-AP4 > L-glutamate > (1S,3R)-ACPD, quisqualate.
Collapse
Affiliation(s)
- P J Flor
- CNS Research, Ciba, CH-4002 Basle, Switzerland
| | | | | | | | | | | | | | | | | |
Collapse
|
18
|
Flor PJ, Lukic S, Rüegg D, Leonhardt T, Knöpfel T, Kuhn R. Molecular cloning, functional expression and pharmacological characterization of the human metabotropic glutamate receptor type 4. Neuropharmacology 1995; 34:149-55. [PMID: 7617140 DOI: 10.1016/0028-3908(94)00149-m] [Citation(s) in RCA: 48] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
A cDNA encoding the human metabotropic glutamate receptor type 4 (hmGluR4) was isolated from human brain cDNA libraries by cross-hybridization with rat mGluR4 probes. The deduced amino acid sequence of human mGluR4 consists of 912 residues and shows a sequence identity of 96% to the amino acid sequence of rat mGluR4. Northern blot analyses indicate that hmGluR4 is strongly expressed in the cerebellum of the adult human brain but also at low levels in hippocampus, hypothalamus and thalamus. Stimulation of hmGluR4 with L-2-amino-4-phosphonobutyrate (L-AP4), L-serine-O-phosphate (L-SOP), L-glutamate or (1S,3R)-1-aminocyclo-pentane-1,3-dicarboxylic acid ((1S,3R)-ACPD) in stably transfected Chinese hamster ovary (CHO) cells depressed forskolin-induced cAMP accumulation, whereas quisqualate (0.5 mM) was ineffective. The rank order of agonist potencies is: L-AP4 > L-SOP > L-glutamate > (1S,3R)-ACPD >> quisqualate. (R,S)-alpha-methyl-4-carboxyphenylglycine (1 mM), a reported antagonist at some mGluR subtypes, did not reduce the depression of forskolin-induced cAMP accumulation by L-AP4.
Collapse
Affiliation(s)
- P J Flor
- Molecular and Cellular Biology, CNS Research, Basle, Switzerland
| | | | | | | | | | | |
Collapse
|
19
|
Fuhrmann E, Pfeiffer L, Zschenderlein R, Leonhardt T, Melster U, Kölmel HW. [Clinico-genetic diagnosis of ataxia telangiectatica (Louis-Bar syndrome)]. Nervenarzt 1993; 64:140-2. [PMID: 8450897] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
Abstract
We describe the possible difficulties in getting the diagnosis "ataxia telangiectasia" using the example of a 16 years old girl. If cases of cerebellar ataxia in childhood present without classical symptoms, the diagnosis of ataxia telangiectasia should not be excluded before chromosome analysis. In our case, first signs of cerebellar ataxia were observed from the age of 11 years and we found only mild, atypical located and late onset telangiectasis. Other signs of the syndrome, such as elevated alpha-fetoproteine and deficiency of IgA or IgE could not be detected. Chromosome analysis, however, demonstrated a breakage syndrome with chromosome 14 to 7 translocation and established a firm diagnosis of ataxia telangiectasia. Patients with chromosome breakage syndromes including the Louis-Bar-syndrome have an increased risk for malignomas. Therefore chromosome analysis should be undertaken in cases of children with cerebellar ataxia, and frequent radiological examination avoided.
Collapse
Affiliation(s)
- E Fuhrmann
- Neurologische Klinik, Medizinische Fakultät (Charité), Humboldt-Universität, Berlin
| | | | | | | | | | | |
Collapse
|
20
|
Leonhardt T. [From the golden years to the stormy years--role of the head of the clinical department through 4 decades]. Lakartidningen 1992; 89:2227-9. [PMID: 1630257] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Affiliation(s)
- T Leonhardt
- Medicinkliniken, Norra Alvsborgs Länssjukhus i Trollhättan
| |
Collapse
|
21
|
Abstract
A woman died at the age of 22 years. Lifetime diagnosis had been inflammatory arachnopathy. The course of the disease had taken at least 6 years. Autopsy revealed primary diffuse leptomeningeal astrocytoma of the brain and spinal cord without neoplastic foci in the parenchyma of the central nervous system. Patchy dystrophic calcifications were recorded from the cerebral and cerebellar cortex.
Collapse
Affiliation(s)
- W Jänisch
- Institut für Pathologie, Medizinischen Fakultät (Charité) der Humboldt-Universität zu Berlin, Deutschland
| | | | | |
Collapse
|
22
|
Bernasconi R, Martin P, Steulet AF, Portet C, Leonhardt T, Schmutz M. Effects of benzodiazepine receptor ligands with different intrinsic activities on seizures induced by inhibition of GAD. Epilepsy Res Suppl 1992; 8:87-96. [PMID: 1358105 DOI: 10.1016/b978-0-444-89710-7.50017-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 03/25/2023]
Affiliation(s)
- R Bernasconi
- Research and Development Department, Ciba-Geigy Ltd., Basel, Switzerland
| | | | | | | | | | | |
Collapse
|
23
|
Bernasconi R, Lauber J, Marescaux C, Vergnes M, Martin P, Rubio V, Leonhardt T, Reymann N, Bittiger H. Experimental absence seizures: potential role of gamma-hydroxybutyric acid and GABAB receptors. J Neural Transm Suppl 1992; 35:155-77. [PMID: 1324978 DOI: 10.1007/978-3-7091-9206-1_11] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Abstract
We have investigated whether the pathogenesis of spontaneous generalized non-convulsive seizures in rats with genetic absence epilepsy is due to an increase in the brain levels of gamma-hydroxybutyric acid (GHB) or in the rate of its synthesis. Concentrations of GHB or of its precursor gamma-butyrolactone (GBL) were measured with a new GC/MS technique which allows the simultaneous assessment of GHB and GBL. The rate of GHB synthesis was estimated from the increase in GHB levels after inhibition of its catabolism with valproate. The results of this study do not indicate significant differences in GHB or GBL levels, or in their rates of synthesis in rats showing spike-and-wave discharges (SWD) as compared to rats without SWD. Binding data indicate that GHB, but not GBL, has a selective, although weak affinity for GABAB receptors (IC50 = 150 microM). Similar IC50 values were observed in membranes prepared from rats showing SWD and from control rats. The average GHB brain levels of 2.12 +/- 0.23 nmol/g measured in the cortex and of 4.28 +/- 0.90 nmol/g in the thalamus are much lower than the concentrations necessary to occupy a major part of the GABAB receptors. It is unlikely that local accumulations of GHB reach concentrations 30-70-fold higher than the average brain levels. After injection of 3.5 mmol/kg GBL, a dose sufficient to induce SWD, brain concentrations reach 240 +/- 31 nmol/g (Snead, 1991) and GHB could thus stimulate the GABAB receptor. Like the selective and potent GABAB receptor agonist R(-)-baclofen, GHB causes a dose-related decrease in cerebellar cGMP. This decrease and the increase in SWD caused by R(-)-baclofen were completely blocked by the selective and potent GABAB receptor antagonist CGP 35348, whereas only the increase in the duration of SWD induced by GHB was totally antagonized by CGP 35348. The decrease in cerebellar cGMP levels elicited by GHB was only partially antagonized by CGP 35348. These findings suggest that all effects of R(-)-baclofen are mediated by the GABAB receptor, whereas only the induction of SWD by GHB is dependent on GABAB receptor mediation, the decrease in cGMP being only partially so. Taken together with the observations of Marescaux et al. (1992), these results indicate that GABAB receptors are of primary importance in experimental absence epilepsy and that GABAB receptor antagonists may represent a new class of anti-absence drugs.
Collapse
Affiliation(s)
- R Bernasconi
- Research and Development Department, Ciba-Geigy, Basel, Switzerland
| | | | | | | | | | | | | | | | | |
Collapse
|
24
|
Abstract
Three patients are reported who developed liver enzyme abnormalities of a cholestatic pattern, without jaundice, after 10-28 d of heparin treatment. The values normalized within 4 months in all patients. Thus heparin should be added to the list of drugs that may cause a cholestatic liver reaction.
Collapse
Affiliation(s)
- R Olsson
- Department of Medicine II, Sahlgrenska University Hospital, Göteborg, Sweden
| | | |
Collapse
|
25
|
Steulet AF, Hauser K, Martin P, Leonhardt T, Bandelier V, Gunst F, Bernasconi R. Reversal by apomorphine of the gabaculine-induced GABA accumulation in mouse cortex. Eur J Pharmacol 1989; 174:161-70. [PMID: 2630298 DOI: 10.1016/0014-2999(89)90308-7] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
To test the assumption that in the mice cortex the rate of accumulation of gamma-aminobutyric acid (GABA) after irreversible inhibition of 4-aminobutyrate: 2-oxoglutarate aminotransferase (EC 2.6.1.19; GABA-T) represents an index of GABA turnover, we examined whether the reversal of the gabaculine-induced accumulation of GABA elicited by apomorphine was due to a decrease in GABA turnover or to a modulation of the activity of the GABA-T inhibitor. Therefore, we simultaneously measured the action of apomorphine on gabaculine-induced accumulation of GABA and on GABA-T activity. In vitro, apomorphine (3 and 30 microM) did not alter the concentration-dependent inhibition of GABA-T by gabaculine. Ex vivo, apomorphine (2 x 0.5 mg/kg s.c.) markedly decreased (69%) gabaculine-induced (150 mg/kg i.p.) accumulation of GABA. This drug had no direct effect on GABA-T activity, but significantly reduced from 83 to 71% the inhibition of GABA-T by gabaculine. The linear correlation found between GABA levels and GABA-T activity allowed the quantification of the decrease in GABA turnover elicited by apomorphine. The results showed that apomorphine decreased significantly (P less than 0.001) the rate of GABA synthesis from 7.48 to 3.36 micromol GABA/g per h, if the partial reversal of gabaculine-induced inhibition of GABA-T is considered and 2.44 micromol/g per h if not. Apomorphine effect on GABA accumulation is mainly due to a decrease of the rate of GABA synthesis and to a lesser extent to a reversal of the inhibitory activity of gabaculine. Thus, inhibition of GABA-T by gabaculine is a sensitive and reliable method for the estimation of the rate of synthesis.
Collapse
Affiliation(s)
- A F Steulet
- Research Department, Ciba-Geigy Ltd., Basel, Switzerland
| | | | | | | | | | | | | |
Collapse
|
26
|
Bernasconi R, Steulet AF, Aryee D, Martin P, Leonhardt T, Bischoff S, Maitre L. [Interactions of GABAergic and catecholaminergic neurotransmissions. Effects of dopaminergic and noradrenergic agonists and antagonists on GABA turnover]. Encephale 1989; 15:377-85. [PMID: 2572414] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
The effects of specific D1 and D2 agonists and antagonists on GABA turnover in four brain structures have been studied. GABA turnover was estimated by measuring the accumulation of GABA after GABA-T inhibition with gabaculine. Stimulation of DA receptors by apomorphine, a mixed D1 and D2 agonist or by (+/-)2-(N-phenylethyl-N-propyl)amino-5-hydroxytetraline, a selective agonist of D2 receptors, dose-dependently reduced GABA turnover. Both agonists had no effect on GABA levels. S(-)sulpiride, a selective D2 antagonist, had no effect on either GABA levels or GABA turnover. However, sulpiride antagonized the reduction of GABA turnover produced by apomorphine or (+/-)2-(N-phenylethyl-N-propyl)amino-5-hydroxytetraline. By contrast, SKF 38393, a selective D1 agonist, did not appear to influence GABA-mediated inhibitory neurotransmission. SCH 23390, a D1 antagonist, which by itself had no effect on GABA levels and only slightly decreased GABA turnover, did not antagonize the effect of apomorphine. On the contrary, SCH 23390, slightly, but significantly increased the reduction in GABA turnover produced by apomorphine. Furthermore, idaxozan, an alpha 2-antagonist, antagonized the reduction of GABA turnover produced by the alpha 2-agonist clonidine, but did not prevent the effect of apomorphine on GABA turnover. Thus, the tonic inhibition exerted by DA on GABA-mediated neurotransmission seems to be mainly controlled by D2 receptors.
Collapse
Affiliation(s)
- R Bernasconi
- Laboratoires de recherche biologique, Ciba-Geigy Ltd, Bâle, Suisse
| | | | | | | | | | | | | |
Collapse
|
27
|
Leonhardt T, Mulec H. [Insulin pump in intractable diabetes during pregnancy]. Lakartidningen 1984; 81:4510-1. [PMID: 6521560] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
|
28
|
Mulec E, Leonhardt T. [Münchhausen's syndrome and drug addiction--a vagabondized and care demanding patient]. Lakartidningen 1982; 79:2721. [PMID: 7144356] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/23/2023]
|
29
|
Seffner W, Leonhardt T, Domel G. [Thyroid function of swine after various types of motor and transportation stress]. Arch Exp Veterinarmed 1982; 36:809-814. [PMID: 7168597] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/21/2023]
|
30
|
Leonhardt T, Samuelson G, Spetz S. [Experiences of care of pregnant diabetics at a country hospital]. Lakartidningen 1978; 75:2709-11. [PMID: 682751] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
|
31
|
Andersson C, Leonhardt T, Stubelius L, Svedberg S. [A case of paracetamol poisoning with reversible liver damage--some reflections]. Lakartidningen 1976; 73:1726-8. [PMID: 1263708] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
|
32
|
Leonhardt T, Skoogh BE, Wettre S. [Construction of the physician service schedule in a medical clinic]. Lakartidningen 1975; 72:2998-3000. [PMID: 1177549] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
|
33
|
Leonhardt T. [Planning of medical service now and in the future]. Lakartidningen 1975; 72:2810-1. [PMID: 1142917] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
|
34
|
Leonhardt T. [Externship, shorter working hours and the function of medical clinics]. Lakartidningen 1972; 69:3662-3. [PMID: 5070380] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
|
35
|
Abjörn C, Leonhardt T. [Anaphylactic shock with fatal outcome after injection of synthetic corticotropin (Synacthen Depot) in a patient with severe asthma]. Lakartidningen 1970; 67:4364-6. [PMID: 4319253] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
|
36
|
Axelsson H, Leonhardt T, Ringqvist T. [A case of essential cryofibrinogenemia--a rare type of cryopathy]. Lakartidningen 1969; 66:2484-6. [PMID: 5799521] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/16/2023]
|
37
|
|
38
|
Leonhardt T. [A case of Weber-Christian syndrome]. Lakartidningen 1967; 64:858-61. [PMID: 6081952] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
|
39
|
Leonhardt T. [Systemic lupus erythematosus (SLE)--a complex autoimmune disorder]. Lakartidningen 1965; 62:2545-55. [PMID: 5868083] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
|
40
|
Leonhardt T. [Systemic lupus erythematosus (SLE)--a multifaceted syndrome]. Lakartidningen 1965; 62:2452-61. [PMID: 5870224] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/17/2023]
|